CN Patent

CN103687593B — 组织蛋白酶k抑制用于治疗和/或预防肺动脉高压和/或心力衰竭的用途

Assigned to Bayer Pharma AG · Expires 2016-09-28 · 10y expired

What this patent protects

组织蛋白酶K抑制用于治疗和/或预防肺动脉高压和/或心力衰竭的用途。摘要：本发明涉及组织蛋白酶K和/或组织蛋白酶S抑制剂在用于治疗和/或预防肺动脉高压和/或心力衰竭的方法中的用途。

USPTO Abstract

组织蛋白酶K抑制用于治疗和/或预防肺动脉高压和/或心力衰竭的用途。摘要：本发明涉及组织蛋白酶K和/或组织蛋白酶S抑制剂在用于治疗和/或预防肺动脉高压和/或心力衰竭的方法中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103687593B
Jurisdiction
CN
Classification
—
Expires
2016-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.